323 related articles for article (PubMed ID: 16087719)
21. Glucagon-like peptide-1 and islet lipolysis.
Sörhede Winzell M; Ahrén B
Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
[TBL] [Abstract][Full Text] [Related]
22. Cell signalling of the GLP-1 action in rat liver.
Redondo A; Trigo MV; Acitores A; Valverde I; Villanueva-Peñacarrillo ML
Mol Cell Endocrinol; 2003 Jun; 204(1-2):43-50. PubMed ID: 12850280
[TBL] [Abstract][Full Text] [Related]
23. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327
[TBL] [Abstract][Full Text] [Related]
24. Glucagon-like peptide-1(7-36)amide enhances insulin-stimulated glucose uptake and decreases intracellular cAMP content in isolated rat adipocytes.
Miki H; Namba M; Nishimura T; Mineo I; Matsumura T; Miyagawa J; Nakajima H; Kuwajima M; Hanafusa T; Matsuzawa Y
Biochim Biophys Acta; 1996 Jun; 1312(2):132-6. PubMed ID: 8672535
[TBL] [Abstract][Full Text] [Related]
25. Effects of preproglucagon-derived peptides and exendins on steroid-hormone secretion from dispersed adrenocortical cells of normal and streptozotocin-induced diabetic rats.
Malendowicz LK; Spinazzi R; Nussdorfer GG; Trejter M
Int J Mol Med; 2003 Jul; 12(1):115-9. PubMed ID: 12792820
[TBL] [Abstract][Full Text] [Related]
26. Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells.
Buteau J; Roduit R; Susini S; Prentki M
Diabetologia; 1999 Jul; 42(7):856-64. PubMed ID: 10440129
[TBL] [Abstract][Full Text] [Related]
27. Novel signal transduction and peptide specificity of glucagon-like peptide receptor in 3T3-L1 adipocytes.
Montrose-Rafizadeh C; Yang H; Wang Y; Roth J; Montrose MH; Adams LG
J Cell Physiol; 1997 Sep; 172(3):275-83. PubMed ID: 9284947
[TBL] [Abstract][Full Text] [Related]
28. Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans.
Vella A; Shah P; Reed AS; Adkins AS; Basu R; Rizza RA
Diabetologia; 2002 Oct; 45(10):1410-5. PubMed ID: 12378382
[TBL] [Abstract][Full Text] [Related]
29. Protein kinase Czeta activation mediates glucagon-like peptide-1-induced pancreatic beta-cell proliferation.
Buteau J; Foisy S; Rhodes CJ; Carpenter L; Biden TJ; Prentki M
Diabetes; 2001 Oct; 50(10):2237-43. PubMed ID: 11574404
[TBL] [Abstract][Full Text] [Related]
30. Divergent effects of GLP-1 analogs exendin-4 and exendin-9 on the expression of myosin heavy chain isoforms in C2C12 myotubes.
Wang L; Guo F; Wei S; Zhao R
Peptides; 2011 Jun; 32(6):1313-9. PubMed ID: 21453734
[TBL] [Abstract][Full Text] [Related]
31. Pancreatic and extrapancreatic effects of GLP-1.
Valverde I; Villanueva-Peñacarrillo ML; Malaisse WJ
Diabetes Metab; 2002 Dec; 28(6 Pt 2):3S85-9; discussion 3S108-12. PubMed ID: 12688638
[TBL] [Abstract][Full Text] [Related]
32. Over-expression of the glucagon-like peptide-1 receptor on INS-1 cells confers autocrine stimulation of insulin gene promoter activity: a strategy for production of pancreatic beta-cell lines for use in transplantation.
Chepurny OG; Holz GG
Cell Tissue Res; 2002 Feb; 307(2):191-201. PubMed ID: 11845326
[TBL] [Abstract][Full Text] [Related]
33. Glucagon-like peptide-1(7-36) amide (GLP-1) enhances insulin-stimulated glucose metabolism in 3T3-L1 adipocytes: one of several potential extrapancreatic sites of GLP-1 action.
Egan JM; Montrose-Rafizadeh C; Wang Y; Bernier M; Roth J
Endocrinology; 1994 Nov; 135(5):2070-5. PubMed ID: 7956929
[TBL] [Abstract][Full Text] [Related]
34. Regulation of glucose transporters and hexose uptake in 3T3-L1 adipocytes: glucagon-like peptide-1 and insulin interactions.
Wang Y; Kole HK; Montrose-Rafizadeh C; Perfetti R; Bernier M; Egan JM
J Mol Endocrinol; 1997 Dec; 19(3):241-8. PubMed ID: 9460645
[TBL] [Abstract][Full Text] [Related]
35. Glucagon-like peptide-1(7-36)-amide confers glucose sensitivity to previously glucose-incompetent beta-cells in diabetic rats: in vivo and in vitro studies.
Dachicourt N; Serradas P; Bailbé D; Kergoat M; Doaré L; Portha B
J Endocrinol; 1997 Nov; 155(2):369-76. PubMed ID: 9415071
[TBL] [Abstract][Full Text] [Related]
36. Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor.
Nuche-Berenguer B; Portal-Núñez S; Moreno P; González N; Acitores A; López-Herradón A; Esbrit P; Valverde I; Villanueva-Peñacarrillo ML
J Cell Physiol; 2010 Nov; 225(2):585-92. PubMed ID: 20506394
[TBL] [Abstract][Full Text] [Related]
37. Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4.
Perry T; Haughey NJ; Mattson MP; Egan JM; Greig NH
J Pharmacol Exp Ther; 2002 Sep; 302(3):881-8. PubMed ID: 12183643
[TBL] [Abstract][Full Text] [Related]
38. Effect of exendin-4 treatment upon glucose uptake parameters in rat liver and muscle, in normal and type 2 diabetic state.
Arnés L; Moreno P; Nuche-Berenguer B; Valverde I; Villanueva-Peñacarrillo ML
Regul Pept; 2009 Feb; 153(1-3):88-92. PubMed ID: 18804493
[TBL] [Abstract][Full Text] [Related]
39. Insulinotropin PACAP potentiates insulin action. Stimulation of glucose uptake in 3T3-LI adipocytes.
Yada T; Nakata M; Shioda S
Ann N Y Acad Sci; 2000; 921():473-7. PubMed ID: 11193879
[TBL] [Abstract][Full Text] [Related]
40. Protein kinase B activity is required for the effects of insulin on lipid metabolism in adipocytes.
Berggreen C; Gormand A; Omar B; Degerman E; Göransson O
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E635-46. PubMed ID: 19158325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
